Molecular profile of the BCL2 family of the apoptosis related genes in breast cancer cells after treatment with cytotoxic/cytostatic drugs

Connective Tissue Research

Volumn 49, Issue 3-4, 2008, Pages 261-264

  Thomadaki, Hellinida ^a   Scorilas, Andreas ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Apoptosis; BAX; BCL2 (bcl 2); BCL2L12 cell lines; Breast cancer; Chemotherapeutic drugs; Chemotherapy; FAS; PCR

Indexed keywords

2 CYANO 3,12 DIOXOOLEANA 1,9 DIEN 28 OIC ACID; BASIC FIBROBLAST GROWTH FACTOR; BENZO[A]PYRENE; BUTYRIC ACID; CAMPTOTHECIN; CARBOPLATIN; CD40 LIGAND; CISPLATIN; CURCUMIN; CYTOSTATIC AGENT; CYTOTOXIC AGENT; DOXORUBICIN; ELLAGITANNIN; ESTROGEN; ETOPOSIDE; FLAVOPIRIDOL; FLUOROURACIL; FULVESTRANT; GENISTEIN; ISOFLAVONE; LINDANE; MESSENGER RNA; MITOBRONITOL; PACLITAXEL; PROLACTIN; PROTEIN BCL 2; RAPAMYCIN; RUGOSIN E; TAMOXIFEN; UNINDEXED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER INHIBITION; CELL STRAIN MCF 7; DOWN REGULATION; DRUG RESPONSE; GENE EXPRESSION; HUMAN; MOLECULAR BIOLOGY; NONHUMAN; PROGNOSIS; PROTEIN FAMILY; REVIEW; TRANSCRIPTION REGULATION;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BREAST NEOPLASMS; CYTOSTATIC AGENTS; DOWN-REGULATION; GENES, BCL-2; HUMANS; PROTO-ONCOGENE PROTEINS C-BCL-2; UP-REGULATION;

EID: 48549092932     PISSN: 03008207     EISSN: 16078438     Source Type: Journal    
DOI: 10.1080/03008200802147829     Document Type: Review

References (34)

1. Thomadaki, H. and Scorilas, A. (2006) BCL2 family of apoptosis-related genes: Functions and clinical implications in cancer. 43, pp. 1-67.
2. Scorilas, A., Kyriakopoulou, L., Yousef, GM., Ashworth, L., Kwamie, A. and Diamandis, E. P. (2001) Molecular cloning, physical mapping and expression analysis of a novel gene, BCL2L12, encoding for a proline-rich protein with a highly conserved BH2 domain of the Bcl-2 family. 72, pp. 217-221.
3. Thomadaki, H., Talieri, M. and Scorilas, A. (2007) Prognostic value of the apoptosis related genes. BCL2 and BCL2L12 in breast cancer. 247:1, pp. 48-55.
4. Mathioudaki, K., Scorilas, A., Papadokostopoulou, A., Xynopoulos, D., Arnogianaki, N., Agnanti, N. and Talieri, M. (2004) Expression analysis of BCL2L12, a new member of apoptosis-related genes, in colon cancer. 385:9, pp. 779-783.
5. Floros, K. V., Thomadaki, H., Lallas, G., Katsaros, N., Talieri, M. and Scorilas, A. (2003) Cisplatin-induced apoptosis in HL-60 human promyelocytic leukemia cells: Differential expression of BCL2 and novel apoptosis-related gene BCL2L12. 1010, pp. 153-158.
6. Lloyd, D. R. and Hanawalt, P. C. (2000) p53-dependent global genomic repair of benzo-[a]pyrene-7,8-diol-9,10-epoxide adducts in human cells. 60, pp. 517-521.
7. Lin, C. C., Tsai, Y. L., Huang, M. T., Lu, Y. P., Ho, C. T., Tseng, S. F. and Teng, S. C. (2006) Inhibition of estradiol-induced mammary proliferation by dibenzoylmethane through the E2-ER-ERE-dependent pathway. 27, pp. 131-136.
8. Meinking, T. L., Serrano, L., Hard, B., Entzel, P., Lemard, G., Rivera, E. and Villar, M. E. (2002) Comparative in vitro pediculicidal efficacy of treatments in a resistant head lice population in the United States. 38, pp. 220-224.
9. Kalantzi, O. I., Hewitt, R., Ford, K. J., Cooper, L., Alcock, R. E., Thomas, G. O., Morris, J. A., McMillan, T. J., Jones, K. C. and Martin, F. L. (2004) Low dose induction of micronuclei by lindane. 25, pp. 613-622.
10. Wittmann, S., Bali, P., Donapaty, S., Nimmanapalli, R., Guo, F., Yamaguchi, H., Huang, M., Jove, R., Wang, H. G. and Bhalla, K. (2003) Flavopiridol downregulates antiapoptotic proteins and sensitizes human breast cancer cells to epothilone B-induced apoptosis. 63, pp. 93-99.
11. Tong, A. W., Papayoti, M. H., Netto, G., Armstrong, D. T., Ordonez, G., Lawson, J. M. and Stone, M. J. (2001) Growth-inhibitory effects of CD40 ligand (CD154) and its endogenous expression in human breast cancer. 7, pp. 691-703.
12. Kilgore, M. W., Tate, P. L., Pai, S., Sengoku, E. and Price, T. M. (1997) MCF-7 and T47D human breast cancer cells contain a functional peroxisomal response. 129, pp. 229-235.
13. Kuo, P. L., Hsu, Y. L., Lin, T. C., Tzeng, W. S., Chen, Y. Y. and Lin, C. C. (2007) Rugosin E, an ellagitannin, inhibits MDA-MB-231 human breast cancer cell proliferation and induces apoptosis by inhibiting nuclear factor-kappaB signaling pathway. 248, pp. 280-291.
14. Poma, P., Notarbartolo, M., Labbozzetta, M., Maurici, A., Carina, V., Alaimo, A., Rizzi, M., Simoni, D. and D'Alessandro, N. (2007) The antitumor activities of curcumin and of its isoxazole analogue are not affected by multiple gene expression changes in an MDR model of the MCF-7 breast cancer cell line: Analysis of the possible molecular basis. 20, pp. 329-335.
15. Ramachandran, C., Rodriguez, S., Ramachandran, R., Raveendran Nair, P.K., Fonseca, H., Khatib, Z., Escalon, E. and Melnick, S. J. (2005) Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. 25, pp. 3293-3302.
16. Siethoff, C., Orth, M., Ortling, A., Brendel, E. and Wagner-Redeker, W. (2004) Simultaneous determination of capecitabine and its metabolite 5-fluorouracil by column switching and liquid chromatographic/tandem mass spectrometry. 39, pp. 884-889.
17. Hernandez-Vargas, H., Ballestar, E., Carmona-Saez, P., von Kobbe, C., Banon-Rodriguez, I., Esteller, M., Moreno-Bueno, G. and Palacios, J. (2006) Transcriptional profiling of MCF7 breast cancer cells in response to 5-Fluorouracil: Relationship with cell cycle changes and apoptosis, and identification of novel targets of p53. 119, pp. 1164-1175.
18. Dave, B., Eason, R. R., Till, S. R., Geng, Y., Velarde, M. C., Badger, T. M. and Simmen, R. C. (2005) The soy isoflavone genistein promotes apoptosis in mammary epithelial cells by inducing the tumor suppressor PTEN. 26, pp. 1793-1803.
19. Sarkar, F. H. and Li, Y. (2002) Mechanisms of cancer chemoprevention by soy isoflavone genistein. 21, pp. 265-280.
20. Lamartiniere, C. A., Moore, J. B., Brown, N. M., Thompson, R., Hardin, M. J. and Barnes, S. (1995) Genistein suppresses mammary cancer in rats. 16, pp. 2833-2840.
21. Somai, S., Gompel, A., Rostene, W. and Forgez, P. (2002) Neurotensin counteracts apoptosis in breast cancer cells. 295, pp. 482-488.
22. Kasukabe, T., Okabe-Kado, J., Kato, N., Sassa, T. and Honma, Y. (2005) Effects of combined treatment with rapamycin and cotylenin A, a novel differentiation-inducing agent, on human breast carcinoma MCF-7 cells and xenografts. 7, pp. R1097-R1110.
23. Fenig, E., Livnat, T., Sharkon-Polak, S., Wasserman, L., Beery, E., Lilling, G., Yahalom, J., Wieder, R. and Nordenberg, J. (1999) Basic fibroblast growth factor potentiates cisplatinum-induced cytotoxicity in MCF-7 human breast cancer cells. 125, pp. 556-562.
24. Diel, P., Smolnikar, K. and Michna, H. (1999) The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL2 than tamoxifen in MCF-7 cells. 58, pp. 87-97.
25. Leung, L. K. and Wang, T. T. (1999) Differential effects of chemotherapeutic agents on the BCL2/Bax apoptosis pathway in human breast cancer cell line MCF-7. 55, pp. 73-83.
26. Thomadaki, H. and Scorilas, A. (2007) Breast cancer cells response to the antineoplastic agents cisplatin, carboplatin, and doxorubicin at the mRNA expression levels of distinct apoptosis-related genes, including the new member, BCL2L12. 1095, pp. 35-44.
27. Liu, J. W., Chandra, D., Rudd, M. D., Butler, A. P., Pallotta, V., Brown, D., Coffer, P. J. and Tang, D. G. (2005) Induction of prosurvival molecules by apoptotic stimuli: Involvement of FOXO3a and ROS. 24, pp. 2020-2031.
28. Thomadaki, H., Talieri, M. and Scorilas, A. (2006) Treatment of MCF-7 cells with taxol and etoposide induces distinct alterations in the expression of apoptosis-related genes BCL2, BCL2L12, BAX, CASPASE-9 and FAS. 387, pp. 1081-1086.
29. Sunters, A., Fernandez de Mattos, S., Stahl, M., Brosens, J. J., Zoumpoulidou, G., Saunders, C. A., Coffer, P. J., Medema, R. H., Coombes, R. C. and Lam, E. W. (2003) FoxO3a transcriptional regulation of Bim controls apoptosis in paclitaxel-treated breast cancer cell lines. 278, pp. 49795-49805.
30. Beck, M. T., Peirce, S. K. and Chen, W. Y. (2002) Regulation of BCL2 gene expression in human breast cancer cells by prolactin and its antagonist, hPRL-G129R. 21, pp. 5047-5055.
31. Wang, T. T. and Phang, J. M. (1995) Effects of estrogen on apoptotic pathways in human breast cancer cell line MCF-7. 55, pp. 2487-2490.
32. Gompel, A., Somai, S., Chaouat, M., Kazem, A., Kloosterboer, H. J., Beusman, I., Forgez, P., Mimoun, M. and Rostene, W. (2000) Hormonal regulation of apoptosis in breast cells and tissues. 65, pp. 593-598.
33. Frasor, J., Danes, J. M., Komm, B., Chang, K. C., Lyttle, C. R. and Katzenellenbogen, B. S. (2003) Profiling of estrogen up- and down-regulated gene expression in human breast cancer cells: Insights into gene networks and pathways underlying estrogenic control of proliferation and cell phenotype. 144, pp. 4562-4574.
34. Mandal, M. and Kumar, R. (1996) BCL2 expression regulates sodium butyrate-induced apoptosis in human MCF-7 breast cancer cells. 7, pp. 311-318.